Latest Announcements

Privi Speciality Chemicals Ltd has announced an analyst/investor meet to discuss Q2 and H1 FY27 earnings on October 30, 2026.

Nilkanth Engineering Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/11/2026 to consider and approve Un-audited Financial Results for half year and Quarter ended 30.09.2026.

Adani Total Gas Ltd has submitted the audio recording of its analysts/investors call pertaining to unaudited financial results for the quarter and half year ended September 30, 2026.

Rainbow Children's Medicare Ltd has announced a schedule for an earnings conference call to discuss its unaudited financial results for the quarter ended September 30, 2026.

CyberTech Systems and Software Ltd has published unaudited financial results for the quarter and half year ended September 30, 2026, showing a net loss of Rs. 1.51 lacs and a net loss of Rs. 0.33 lacs for the quarter and half year respectively. The company's equity share capital remains unchanged at Rs. 195 lacs, with an earning per share of Rs. 10.00.

DCM Nouvelle Ltd has scheduled a Board Meeting on October 30, 2026, to consider and approve unaudited Financial results for the quarter and half year ended September 30, 2026.

Tata Motors Ltd has submitted an investor presentation for Q2 and H1 FY27 results, highlighting key highlights, corporate actions, and financials.

CyberTech Systems and Software Ltd reported Q2FY27 revenue of ₹ 780.3 million, up 16.9% YoY, with operating revenue increasing 24.7% YoY to ₹ 733.0 million. Profit after tax for the quarter was ₹ 86.8 million, reflecting lower other income compared with the same period last year.

Crisil Ltd has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended September 30, 2026. The company has also approved the payment of a third interim dividend of Rs. 17 per equity share.

Stanrose Mafatlal Investments & Finance Ltd has scheduled a Board Meeting on November 3, 2026, to consider and approve the Unaudited Financial Results for the Second Quarter and half year ended September 30, 2026.

Typhoon Financial Services Ltd has scheduled a Board Meeting on 4th November, 2026 to consider and approve the Unaudited Financial Results for the quarter ended on 30th September, 2026.

Creative Castings Ltd has informed BSE about a Board Meeting scheduled on 31/10/2026 to consider and approve Unaudited Financial Results for the second quarter and half year ended on September 30, 2026.

ISF Ltd has announced its unaudited financial results for the quarter ended 30th September, 2026, with the Board of Directors approving the same. The company has also taken note of the Internal Audit Report, certificate regarding non-applicability of Regulation 23 and 32 of SEBI Listing Regulations, listing compliances, and other matters.

Bank of India has announced its unaudited financial results for the second quarter and half-year ended September 2026, with a net profit of ₹4,29,161 crore and a total income of ₹46,52,720 crore.

Sukhjit Starch & Chemicals Ltd reported a 30.64% YoY revenue growth in Q2 FY27 and 18.20% YoY revenue growth in H1 FY27, with significant improvements in EBITDA and PBT.

Fabtech Technologies Ltd has scheduled a Board Meeting on October 28, 2026, to consider and approve un-audited Standalone and Consolidated Financial Results for the Second Quarter and Half-Year ended September 30, 2026.

JK Tyre & Industries Ltd has announced unaudited financial results for the second quarter and half year ended 30th September 2026, showing revenue from operations at ₹4840.73 crore and ₹8786.97 crore respectively, with a net profit of ₹65.11 crore and ₹109.15 crore respectively.

Emmessar Biotech & Nutrition Ltd has scheduled a Board Meeting on October 31, 2026, to consider and approve unaudited Financial Results for the quarter ended September 30, 2026.

ISF Ltd has declared its financial results for the quarter ended 30th September, 2026, with the Board of Directors approving the unaudited financial statements and a limited review report. The company has also taken note of its internal audit report, certificates regarding non-applicability of certain regulations, and listing compliances. Additionally, the Board has approved a proposal to avail inter-corporate deposits/loans up to ₹11,00,00,000 and considered the Grievance Redressal Policy.

Shukra Pharmaceuticals Ltd has revised its Board Meeting scheduled for 03/11/2026 to 04/11/2026 to consider unaudited financial results for the second quarter and half year ended 30/09/2026.